AZTA Stock Forecast: Azenta, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 96 of 100 as at 21 Nov 2026 — among the strongest tenth.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Azenta, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.
Growth (42): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
AZTA stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AZTA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Of the 20 most recent actions, 4 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 11 Nov 2026 | Jefferies | Maintains | Buy | $44 → $52 |
| 11 Nov 2026 | Needham | Maintains | Buy | $37 → $57 |
| 14 Sept 2026 | Needham | Reiterates | Buy | $37 |
| 6 Aug 2026 | Evercore ISI Group | Maintains | Outperform | $28 → $35 |
| 5 Aug 2026 | Needham | Maintains | Buy | $33 → $37 |
| 6 May 2026 | Needham | Maintains | Buy | $44 → $33 |
| 6 Apr 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 17 Mar 2026 | Needham | Reiterates | Buy | — |
| 5 Feb 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 4 Feb 2026 | Jefferies | Maintains | Buy | — |
| 4 Feb 2026 | Needham | Reiterates | Buy | — |
| 8 Jan 2026 | TD Cowen | Maintains | Hold | — |
| 5 Jan 2026 | Evercore ISI Group | Upgrade | Outperform | — |
| 19 Dec 2025 | Needham | Maintains | Buy | — |
| 25 Nov 2025 | Raymond James | Maintains | Outperform | — |
| 21 Nov 2025 | Needham | Maintains | Buy | — |
| 30 Oct 2025 | Jefferies | Upgrade | Buy | — |
| 6 Aug 2025 | Raymond James | Upgrade | Outperform | — |
| 5 Aug 2025 | Evercore ISI Group | Maintains | In-Line | — |
| 8 July 2025 | Evercore ISI Group | Maintains | In-Line | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
AZTA appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
AZTA vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Azenta, Inc. returned +49.3% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
AZTA analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 3.0×
- Price / book
- 1.3×
- EV / EBITDA
- 46.8×
Cheaper than 37% of US stocks
Cheaper than 59% of US stocks
Cheaper than 7% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 44.9%
- Operating margin
- −3.3%
- Net margin
- —
Higher than 56% of US stocks
Higher than 31% of US stocks
- Return on equity
- −10.1%
- Return on assets
- −0.7%
- Dividend yield
- 0.9%
Higher than 37% of US stocks
Higher than 41% of US stocks
Higher than 17% of US dividend payers
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Azenta, Inc. has a market value of $2.0B and an enterprise value of $1.7B.
Revenue in the twelve months to 30 June 2026: $613.6M. The latest quarter grew 12.0% year on year.
Net income over the same four quarters: −$122.9M, a −20.0% net margin.
Diluted earnings per share, trailing twelve months: −$2.76.
Free cash flow in the twelve months to 30 June 2026: $9.9M.
forward P/E: 50.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.89%.
Azenta, Inc. employs 2,900 people — $212K of revenue per employee.
Data provided by Twelve Data
AZTA and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at AZTA’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Azenta, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about AZTA
How does Ticker Nerd's model rank AZTA?
As at 21 Nov 2026, Azenta, Inc. ranks 96 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).
What is the AZTA stock forecast for 2030?
No analyst covering Azenta, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AZTA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $50 to $57 over the next 12 months.
How has AZTA stock performed over the past year?
Azenta, Inc. returned +49.3% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Azenta, Inc. do?
Azenta, Inc. is a life sciences tools and services company focused on sample management, biostorage, and genomic services. The company provides automated storage systems, temperature-controlled logistics, laboratory consumables, informatics, and repository services that help customers preserve, track, and manage biological and chemical samples across research, clinical development, and commercialization workflows.
About Azenta, Inc.
Azenta, Inc. is a life sciences tools and services company focused on sample management, biostorage, and genomic services. The company provides automated storage systems, temperature-controlled logistics, laboratory consumables, informatics, and repository services that help customers preserve, track, and manage biological and chemical samples across research, clinical development, and commercialization workflows. Azenta also offers sequencing, gene synthesis, and related multiomics services for pharmaceutical, biotechnology, academic, and healthcare customers. Its solutions are used to support drug development, clinical research, advanced therapies, and biospecimen handling, making the company an important provider of infrastructure for sample integrity and data-driven life sciences operations. Azenta is headquartered in Burlington, Massachusetts, and serves a global customer base across North America, Europe, and Asia.
CEO Dr. Martin D. Madaus D.V.M., Ph.D. · 2,900 employees · United States · https://www.azenta.com